UBS Group AG - CUE BIOPHARMA INC ownership

CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 65 filers reported holding CUE BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of CUE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$182,027
-37.9%
79,142
-1.5%
0.00%
Q2 2023$293,139
+41.5%
80,312
+38.4%
0.00%
Q1 2023$207,163
+201.1%
58,029
+140.3%
0.00%
Q4 2022$68,813
+27.4%
24,1450.0%0.00%
Q3 2022$54,000
-23.9%
24,145
-15.0%
0.00%
Q2 2022$71,000
-43.7%
28,421
+10.7%
0.00%
Q1 2022$126,000
-89.8%
25,685
-76.5%
0.00%
Q4 2021$1,236,000
+44.7%
109,299
+86.5%
0.00%
Q3 2021$854,000
+171.1%
58,590
+116.9%
0.00%
Q2 2021$315,000
-50.8%
27,017
-48.5%
0.00%
Q1 2021$640,000
+127.0%
52,422
+132.6%
0.00%
Q4 2020$282,000
-13.2%
22,535
+4.4%
0.00%
Q3 2020$325,000
-38.6%
21,5950.0%0.00%
Q2 2020$529,000
+20.5%
21,595
-30.2%
0.00%
Q1 2020$439,000
-52.9%
30,955
-47.4%
0.00%
Q4 2019$933,000
+128.1%
58,823
+21.3%
0.00%
Q3 2019$409,000
+25.5%
48,513
+33.6%
0.00%
Q2 2019$326,000
+38.7%
36,319
+19.6%
0.00%
Q1 2019$235,000
+34.3%
30,372
-18.7%
0.00%
Q4 2018$175,000
-25.8%
37,355
+43.1%
0.00%
Q3 2018$236,000
-14.2%
26,112
+12.8%
0.00%
Q2 2018$275,000
+428.8%
23,156
+526.7%
0.00%
Q1 2018$52,0003,6950.00%
Other shareholders
CUE BIOPHARMA INC shareholders Q3 2022
NameSharesValueWeighting ↓
Prosight Management, LP 1,545,573$3,447,0001.85%
P.A.W. CAPITAL CORP 200,000$446,0000.67%
SANDERS MORRIS HARRIS LLC 848,048$2,020,0000.50%
Monaco Asset Management SAM 458,851$1,023,0000.39%
Bleichroeder LP 555,000$1,238,0000.26%
APOGEM CAPITAL LLC 110,614$247,0000.25%
Slate Path Capital LP 1,483,619$3,308,0000.22%
Voss Capital, LLC 200,000$446,0000.13%
Robertson Stephens Wealth Management, LLC 478,500$1,067,0000.11%
CARLSON CAPITAL L P 535,000$1,193,0000.09%
View complete list of CUE BIOPHARMA INC shareholders